Lactose (India) Limited

BSE: LACTOSE

BSE

100.30 7.46 (8.04%)

Prev Close

92.84

Open Price

92.84

Volume

23,746

Today Low / High

89.99 / 101

52 WK Low / High

84.27 / 231

Range

95 - 105

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 100.3, reflecting a change of 7.46 (8.03533%). The expected target range on the BSE is 95 - 105. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

22 Aug 92.84 8.04%

21 Aug 91.94 0.98%

20 Aug 96.95 -6.20%

19 Aug 97.60 -5.67%

18 Aug 98.50 -0.89%

14 Aug 99.00 -2.42%

13 Aug 101.95 -3.13%

12 Aug 100.75 -2.19%

11 Aug 100.05 -0.37%

08 Aug 99.17 1.20%

07 Aug 95.21 2.95%

06 Aug 98.75 0.08%

05 Aug 101.00 -1.54%

04 Aug 99.05 0.30%

01 Aug 99.90 -0.76%

31 Jul 95.00 5.26%

30 Jul 99.90 -1.85%

29 Jul 95.10 5.05%

28 Jul 96.25 2.13%

Lactose (India) Limited Graph

If you are looking for the target price for Lactose (India) Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 100.30, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario	Price	Target	Range
Bullish Scenario	100.30	101.30	91.17 - 111.43
		102.31	81.84 - 122.77
		103.31	72.32 - 134.30
Bearish Scenario	100.30	99.30	89.37 - 109.23
		98.29	78.64 - 117.95
		97.29	68.10 - 126.48

ISIN

INE058I01013

Industry

Medical - Pharmaceuticals

Vol.Avg

7,599

Market Cap

1,262,676,700

Last Dividend

Official Website

Visit Website

IPO Date

DCF Diff

63.28

DCF

Financial Ratios Every Investor Needs

Stock Rating Details for LACTOSE

Metric	Value	Recommendation
Overall Rating	B	Neutral
DCF Score	3	Neutral
ROE Score	4	Buy
ROA Score	4	Buy
Debt-to-Equity (DE) Score	1	Strong Sell
Price-to-Earnings (PE) Score	2	Sell
Price-to-Book (PB) Score	3	Neutral

Annual Financial Income Report

Date	Revenue	Co.Rev	GP	GPR	G&A Expenses	Operating Income	Net Income	EPS	EBITDA	NIR
2025-03-31	116.40 Cr	95.02 Cr	21.38 Cr	0.1837	0.00 Cr	11.57 Cr	5.16 Cr	4.02	18.41 Cr	0.0444
2024-03-31	113.89 Cr	88.95 Cr	24.94 Cr	0.2190	10.68 Cr	13.78 Cr	6.79 Cr	5.39	20.12 Cr	0.0596
2023-03-31	64.91 Cr	32.67 Cr	32.25 Cr	0.4968	1.19 Cr	6.77 Cr	1.21 Cr	0.96	12.10 Cr	0.0186
2022-03-31	45.10 Cr	15.67 Cr	29.44 Cr	0.6527	0.86 Cr	7.84 Cr	2.45 Cr	2.10	12.84 Cr	0.0544
2021-03-31	34.31 Cr	12.10 Cr	22.21 Cr	0.6472	0.78 Cr	2.35 Cr	-2.48 Cr	-2.40	6.54 Cr	-0.0722

Annual Financials Balance Sheet

Date	C&C Equ.	Tot. Assets	Tot. Liab.	Stock. Equity	Tot. Debt	Net Debt	Inv.	PP&E (Net)	Curr. Def. Rev.	Non-Curr. Def. Rev.	LT Invest.	Curr. Liab.
2025-03-31	4.93 Cr	133.47 Cr	74.73 Cr	58.7396 Cr	56.83 Cr	51.90 Cr	24.55 Cr	62.51 Cr	0.00 Cr	0.00 Cr	0.00 Cr	44.8896 Cr
2024-03-31	1.53 Cr	100.74 Cr	53.64 Cr	47.0990 Cr	39.25 Cr	37.72 Cr	16.79 Cr	55.31 Cr	0.18 Cr	0.32 Cr	-0.46 Cr	25.3985 Cr
2023-03-31	0.58 Cr	101.78 Cr	61.22 Cr	40.5609 Cr	38.96 Cr	38.38 Cr	22.78 Cr	56.06 Cr	0.03 Cr	0.93 Cr	0.00 Cr	26.5669 Cr
2022-03-31	1.92 Cr	90.22 Cr	50.94 Cr	39.2846 Cr	41.33 Cr	39.40 Cr	7.12 Cr	59.20 Cr	2.17 Cr	0.00 Cr	0.74 Cr	14.9106 Cr
2021-03-31	2.16 Cr	88.34 Cr	53.26 Cr	35.0894 Cr	46.15 Cr	43.98 Cr	8.32 Cr	63.02 Cr	1.06 Cr	0.82 Cr	0.68 Cr	11.6256 Cr

Annual Financials Cash Flow Statement

Date	Operating Cash	Investing Cash	Financing Cash	Free Cash	Cash Change	Cash at End	CapEx	Income	Debt Repay	Inventory
2025-03-31	-5.5816 Cr	-15.5678 Cr	24.1000 Cr	-19.9586 Cr	0.0000 Cr	4.9328 Cr	-14.3770 Cr	5.1629 Cr	18.1188 Cr	-7.7598 Cr
2024-03-31	8.7754 Cr	-2.0789 Cr	-5.7475 Cr	6.5900 Cr	0.9490 Cr	1.5300 Cr	-2.1854 Cr	9.6640 Cr	-0.2962 Cr	5.9863 Cr
2023-03-31	8.0572 Cr	-1.0184 Cr	-8.3811 Cr	6.4966 Cr	-1.3424 Cr	0.5810 Cr	-1.5606 Cr	1.4645 Cr	-2.1086 Cr	-15.6610 Cr
2022-03-31	8.4667 Cr	-0.5616 Cr	-8.1436 Cr	7.1440 Cr	-0.2385 Cr	1.9234 Cr	-1.3227 Cr	3.1663 Cr	-4.6360 Cr	1.2035 Cr
2021-03-31	2.1650 Cr	-6.1764 Cr	4.5237 Cr	-3.3250 Cr	0.5122 Cr	2.1619 Cr	-5.4900 Cr	-3.2704 Cr	6.9862 Cr	0.5865 Cr

Quarterly Financial Income Report

Date	Revenue	Co.Rev	GP	GPR	Operating Income	Net Income	EPS	EBITDA	NIR
2025-03-31	27.77 Cr	23.05 Cr	4.72 Cr	0.1699	2.02 Cr	0.64 Cr	0.50	3.78 Cr	0.0231
2024-12-31	28.72 Cr	20.21 Cr	8.51 Cr	0.2963	1.61 Cr	0.22 Cr	0.17	3.53 Cr	0.0076
2024-09-30	30.45 Cr	24.38 Cr	6.07 Cr	0.1993	3.68 Cr	2.03 Cr	1.61	5.31 Cr	0.0668
2024-06-30	29.46 Cr	22.87 Cr	6.60 Cr	0.2239	4.26 Cr	2.27 Cr	1.80	5.79 Cr	0.0770
2024-03-31	29.40 Cr	22.62 Cr	6.78 Cr	0.2305	4.48 Cr	2.40 Cr	1.91	6.41 Cr	0.0816

Quarterly Financials Balance Sheet

Date	Cash & Equiv.	Short-Term Inv.	Cash & Short-Term	Net Receivables	Inventory	Total Curr. Assets	PP&E (Net)	Total Assets	Total Liabilities
2025-03-31	4.93 Cr	0.00 Cr	4.93 Cr	23.24 Cr	24.55 Cr	57.33 Cr	62.51 Cr	133.47 Cr	74.73 Cr
2024-12-31	0.00 Cr	0.00 Cr	3.33 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	-51.40 Cr
2024-09-30	2.86 Cr	0.58 Cr	3.44 Cr	20.48 Cr	18.36 Cr	46.75 Cr	54.52 Cr	112.99 Cr	61.59 Cr
2024-06-30	0.00 Cr	0.00 Cr	1.86 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	-47.10 Cr
2024-03-31	1.86 Cr	0.46 Cr	1.86 Cr	16.37 Cr	16.79 Cr	35.53 Cr	54.60 Cr	100.74 Cr	53.64 Cr

Quarterly Financials Cash Flow Statement

Date	Net Income	Operating Cash Flow	Net Cash Change	Cash at End	Cash at Beginning	Free Cash Flow
2024-12-31	0.22 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2024-09-30	2.03 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2024-06-30	2.27 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2024-03-31	2.40 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr	0.00 Cr
2023-12-31	2.63 Cr	2.39 Cr	2.39 Cr	2.81 Cr	0.42 Cr	2.39 Cr

Splits History

Date	Label	Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name	Symbol	Price	Market Cap	Volume
MedPlus Health Services Limited	MEDPLUS	₹821.25	₹98,339,283,675.00	₹72,992.00

Key Executives

MD & Director

Mr. Atul Surajmal Maheshwari MBA

Gender: male

Year Born: 1965

Company Secretary & Compliance Officer

Mr. Ritesh A. Kumar Pandey

Gender: male

Year Born: 1986

Chief Financial Officer & Whole Time Director

Ms. Sangita Atul Maheshwari

Gender: female

Year Born: 1967

FAQs about Lactose (India) Limited

Who is the CEO of the company?

The CEO is Atul Surajmal Maheshwari MBA.

What is the current market price of the stock?

The current price is ₹100.30.

What is the 52-week price range?

The range is ₹84.27-231.

What is the market capitalization of the company?

The market capitalization is ₹126.27 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 24.97.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Lactose (India) Limited (ISIN: INE058I01013) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹126.27 crores and an average daily volume of 7,599 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.